First-Trimester Use of Selective Serotonin-Reuptake Inhibitors and the Risk of Birth Defects
Carol Louik(Boston University), Allen A. Mitchell(Boston University), Angela E. Lin(Massachusetts General Hospital), Sonia Hernández–Dı́az(Harvard University), Martha M. Werler(Boston University)
Cited by 497
Related Papers
Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting
|European Journal of Endocrinology|2017|1.1k
De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes
|Nature Genetics|2012|752
Guidelines for case classification for the national birth defects prevention study
|Birth Defects Research Part A Clinical and Molecular Teratology|2003|579
Seeking causes: Classifying and evaluating congenital heart defects in etiologic studies
|Birth Defects Research Part A Clinical and Molecular Teratology|2007|464
CHARGE Association: An Update and Review for the Primary Pediatrician
|Clinical Pediatrics|1998|451